Genentech, long the darling of the biotechnology industry, was acquired by Swiss pharmaceutical company Roche in 2009. The combined company retains the name Genentech in the US, but must now move to achieve the promises made at the time of this merger-to build from made Genentech great. One of the key tasks for Genentech CEO Ian Clark and CFO Ashraf Hanna was to implement a new portfolio management process for the combined entity. This case explores the goals of the portfolio management process, and allows students to actively participate in the portfolio management exercise. The case includes cost and income projections for 12 products that need to be reviewed and approved.

【書誌情報】

ページ数：29ページ

サイズ：A4

商品番号：HBSP-317012

発行日：2016/7/20

登録日：2019/2/21